[1]ZHAO YS, ZHANG LN, LI HC, et al.Clinical significance of serum GP73, AFP, and CA199 test in the diagnosis of hepatic cancer[J].Chin J Gastroenterol Hepatol, 2013, 40 (1) :29-32. (in Chinese) 赵运胜, 张丽娜, 李洪臣, 等.血清GP73联合AFP和CA199检测在肝癌诊断中的临床意义[J].中国肿瘤临床, 2013, 40 (1) :29-32.
|
[2]ZENG YL, MA QF, XIONG W, et al.Relationships between HBV-M patterns and liver function, HBV-DNA in patients with chronic HBV infection of different stages[J].Int J Lab Med, 2015, 36 (4) :433-435. (in Chinese) 曾雅莉, 马清峰, 熊微, 等.不同病期慢性HBV感染者肝功能、HBV-DNA与HBV-M模式的关系[J].国际检验医学杂志, 2015, 36 (4) :433-435.
|
[3]RAIN AJ, CHAN DW.Cancer proteomics:serum diagnostics for tumor marker discovery[J].Ann N Y Acad Sci, 2004, 1022:286-294.
|
[4]SI X, TAN GJ.Value of tumor markers carcinoembryonic antigen, alpha-fetoprotein, and carbohydrate antigen 199 in diagnosis of liver cancer[J].Jilin Med J, 2008, 29 (16) :1392-1393. (in Chinese) 司序, 谭桂菊.探讨肿瘤标志物CEA、AFP、CA199在肝癌诊断中的应用价值[J].吉林医学, 2008, 29 (16) :1392-1393.
|
[5]TIAN MF, HAN B.The clinical value of the detections of CA199, CA125, CA153 and CEA in malignant tumors[J].J Clin Exp Med, 2010, 9 (7) :483-485. (in Chinese) 田满福, 韩波.检测CA199、CA125、CA153及CEA在肿瘤诊断中的意义[J].临床和实验医学杂志, 2010, 9 (7) :483-485.
|
[6]ZHANG N, WANG YX, HU J, et al.Application of levels of serum CA199, C3, C4 and lipid metabolism in clinical diagnosis of pancreatic cancer[J].J Jilin Univ:Med Edit, 2016, 42 (2) :295-300. (in Chinese) 张宁, 王颖娴, 胡健, 等.血清CA199、C3、C4及脂类代谢水平在胰腺癌临床诊断中的应用[J].吉林大学学报, 2016, 42 (2) :295-300.
|
[7]GUO HM.Value of measurement of serum CA199 levels for diagnosis of hepatocirrhosis and carcinoma of liver[J].J Radioimmunol, 2003, 16 (4) :207-208. (in Chinese) 郭红梅.血清CA199在肝硬化与肝癌诊断中的价值[J].放射免疫学杂志, 2003, 16 (4) :207-208.
|
[8]HUANG HT, ZHANG XF.CA199 Clinical significance of carbohydrate antigen 199 in liver cirrhosis and liver cancer[J].J Clin Hepatol, 2006, 22 (5) :379-380. (in Chinese) 黄海涛, 张筱风.CA199在肝硬化和肝癌中的临床意义[J].临床肝胆病杂志, 2006, 22 (5) :379-380.
|
[9]DONG JZ, DENG ZY, ZHANG F, et al.Diagnostic value of combined detection of AFP, CEA and CA199 in primary liver cancers[J].Med J Natl Defend Forces Northwest China, 2011, 32 (4) :276-277. (in Chinese) 董菊子, 邓芝云, 张峰, 等.AFP、CEA和CA199联合检测在原发性肝癌诊断中的应用[J].西北国防医学杂志, 2011, 32 (4) :276-277.
|
[10]ZHU W, GE JL, ZHANG LQ, et al.Clinical value of combined determination of alpha-fetoprotein, carcinoembryonic antigen, carbohydrate antigen 199, and cancer antigen 125 in diagnosis of liver cancer and liver cirrhosis[J].Int J Lab Med, 2012, 33 (15) :1902-1904. (in Chinese) 朱薇, 葛君琍, 张利强, 等.AFP、CEA、CA199、CA-125联合检测对肝癌、肝硬化诊断的临床价值[J].国际检验医学杂志, 2012, 33 (15) :1902-1904.
|
[11]MEI Y, PENG CJ, CHEN L, et al.Early detective value of serum CA199 levels for concomitant acute cholangitis in obstructive jaundice[J].Chin J Pract Surg, 2015, 35 (4) :445-447. (in Chinese) 梅永, 彭瓷军, 陈丽, 等.血清CA199早期预判梗阻性黄疸发生急性胆管炎临床价值研究[J].中国实用外科杂志, 2015, 35 (4) :445-447.
|
[12]RUAN SL, BI J.Influence of liver function on the detection of common tumor markers[J].World Chin J Dig, 2008, 16 (24) :2780-2784. (in Chinese) 阮水良, 毕军.肝功能生化指标对常用肿瘤标志物检测的影响[J].世界华人消化杂志, 2008, 16 (24) :2780-2784.
|
[13]XIN WJ, ZHAO WJ.Combined detection of GP73, AFP and CA-199 in the diagnosis of primary liver cancer[J].Mod Oncol, 2016, 24 (7) :1083-1084. (in Chinese) 辛文娟, 赵文静.GP73、AFP、CA-199联合检测在原发性肝癌诊断中的应用价值[J].现代肿瘤医学, 2016, 24 (7) :1083-1084.
|
[14]ZHENG HL, ZHAO R, LI DP, et al.Utility of DCP and AFP in diagnosis of primary liver cancer[J].Chin J Gen Prac, 2016, 14 (1) :29-31. (in Chinese) 郑海伦, 赵睿, 李大鹏, 等.肿瘤标志物DCP和AFP在原发性肝癌中的诊断价值[J].中华全科医学, 2016, 14 (1) :29-31.
|
[15]ASUM N, CHOWDHURY HUA, CHOWDHURY MR, et al.Correlation of serum alpha-fetoprotein (AFP) level with liver function parameters in hepatitis B virus (HBV) infected patients in Bangladeshi population[J].Int JBiosci, 2012, 2 (9) :13-19.
|
1. | 李斌华,陈小勇,李雷. 加强门静脉高压症的临床管理,促进失代偿性肝硬化再代偿. 肝脏. 2025(02): 262-265 . ![]() | |
2. | 杨晶艳,刘丽萍,陈梅春,周双红. 慢性乙型肝炎患者服药依从性的影响因素分析. 健康研究. 2024(02): 167-171+176 . ![]() | |
3. | 李斌华,谢峰,闫雪华,陈小勇,李雷,王文青. 综合医院MDT模式下肝硬化门静脉高压症患者全病程管理的探讨. 临床医学研究与实践. 2024(36): 182-185 . ![]() | |
4. | 罗发燕,陈铁霞,罗平平,诸伟红. 慢性乙型肝炎患者服药依从性调查. 预防医学. 2023(11): 966-969+974 . ![]() | |
5. | 蔡冬梅,胡婷婷. 网络互动式健康教育对中青年乙型肝炎患者疾病认知及治疗依从性的影响. 中国医药导报. 2022(04): 166-169 . ![]() | |
6. | 吕卉. 慢性病毒性肝炎患者治疗依从性的相关影响因素分析. 当代护士(上旬刊). 2022(01): 58-60 . ![]() | |
7. | 宋如梅,魏芹,李晶,薛群. “3-PR”参与式健康教育对慢性乙肝患者疾病认知及健康行为的影响. 海军医学杂志. 2022(01): 109-112 . ![]() | |
8. | 王玉美,李雪,范琪琪,王爱敏. 青岛慢性乙型肝炎患者抗病毒治疗服药依从性现状及影响因素分析. 社区医学杂志. 2022(04): 228-232 . ![]() | |
9. | 邓娜娜,周美芳. "5个时刻法"用药宣教应用于慢性乙型肝炎抗病毒治疗中的效果. 国际护理学杂志. 2022(06): 1104-1107 . ![]() | |
10. | 沈璐,周翠梅,张静,薛继华,李惠萍. 慢性乙型肝炎患者抗病毒治疗知信行量表的编制及信效度检验. 中国健康教育. 2021(03): 217-221 . ![]() | |
11. | 李振洁. 延伸护理服务在慢性乙型肝炎患者院外护理中的应用. 河南医学研究. 2021(07): 1329-1331 . ![]() | |
12. | 杨玲. 影响慢性乙型肝炎患者服药依从性相关危险因素及其干预措施分析. 内蒙古医学杂志. 2021(07): 836-838 . ![]() | |
13. | 王蕾,王丹,李汝珂,李长安,赵巍峰. “五个时刻法”延续用药指导在慢性乙型肝炎长期抗病毒治疗中的应用价值. 新乡医学院学报. 2021(06): 526-530 . ![]() | |
14. | 钟丽梅,唐霏林,杨柳琴,陆艳珍,黄桂敏,黄艳. 慢性乙型肝炎患者抗病毒治疗期间自我停药状况及影响因素. 河北医药. 2021(17): 2614-2617 . ![]() | |
15. | 田晓英. 医护药一体化模式对慢性乙型肝炎病人用药依从性及负性情绪的影响. 全科护理. 2021(34): 4857-4859 . ![]() | |
16. | 林顺伟,周舒冬,郜艳晖,李粤平,贾卫东,梁颖芳,杨翌. 慢性乙型肝炎患者抗病毒治疗的依从性分析. 临床肝胆病杂志. 2020(03): 532-535 . ![]() | |
17. | 王贵菊,鲁荣华. 1022例慢性乙型肝炎病毒感染者现状及影响因素. 中国卫生工程学. 2020(03): 336-338 . ![]() |